|
1
|
Elmonem MA, Veys KR, Soliman NA, van Dyck
M, van den Heuvel LP and Levtchenko E: Cystinosis: A review.
Orphanet J Rare Dis. 11(47)2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nesterova G and Gahl WA: Cystinosis: The
evolution of a treatable disease. Pediatr Nephrol. 28:51–59.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Curie A, Touil N, Gaillard S, Galanaud D,
Leboucq N, Deschenes G, Morin D, Abad F, Luauté J, Bodenan E, et
al: Neuropsychological and neuroanatomical phenotype in 17 patients
with cystinosis. Orphanet J Rare Dis. 15(59)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Martin-Sabroso C, Alonso-Gonzalez M,
Fernandez-Carballido A, Aparicio-Blanco J, Cordoba-Diaz D,
Navarro-Garcia F, Córdoba-Díaz M and Torres-Suárez AI: Limitations
and challenges in the stability of cysteamine eye drop compounded
formulations. Pharmaceuticals (Basel). 15(2)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Town M, Jean G, Cherqui S, Attard M,
Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates
GP, et al: A novel gene encoding an integral membrane protein is
mutated in nephropathic cystinosis. Nat Genet. 18:319–324.
1998.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gahl WA, Thoene JG and Schneider JA:
Cystinosis. N Engl J Med. 347:111–121. 2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Baumner S and Weber LT: Nephropathic
cystinosis: Symptoms, treatment, and perspectives of a systemic
disease. Front Pediatr. 6(58)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Biswas S, Gaviria M, Malheiro L, Marques
JP, Giordano V and Liang H: Latest clinical approaches in the
ocular management of cystinosis: A review of current practice and
opinion from the ophthalmology cystinosis forum. Ophthalmol Ther.
7:307–322. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Emma F, Montini G, Pennesi M, Peruzzi L,
Verrina E, Goffredo BM, Canalini F, Cassiman D, Rossi S and
Levtchenko E: Biomarkers in nephropathic cystinosis: Current and
future perspectives. Cells. 11(1839)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Gahl WA, Balog JZ and Kleta R:
Nephropathic cystinosis in adults: Natural history and effects of
oral cysteamine therapy. Ann Intern Med. 147:242–250.
2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bradbury JA, Danjoux JP, Voller J, Spencer
M and Brocklebank T: A randomised placebo-controlled trial of
topical cysteamine therapy in patients with nephropathic
cystinosis. Eye (Lond). 5:755–760. 1991.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Makuloluwa AK and Shams F: Cysteamine
hydrochloride eye drop solution for the treatment of corneal
cystine crystal deposits in patients with cystinosis: An
evidence-based review. Clin Ophthalmol. 12:227–236. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Attia R, Fitoussi R, Mairot K, Demortiere
S, Stellman JP, Tilsley P, Audoin B, David T and Stolowy N: Risk
factors associated with progression from papilloedema to optic
atrophy: Results from a cohort of 113 patients. BMJ Open
Ophthalmol. 8(e001375)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Emma F, Nesterova G, Langman C, Labbe A,
Cherqui S, Goodyer P, Janssen MC, Greco M, Topaloglu R, Elenberg E,
et al: Nephropathic cystinosis: an international consensus
document. Nephrol Dial Transplant 29 Suppl. 4 (Suppl 4):iv87–iv94.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ariceta G, Camacho JA, Fernandez-Obispo M,
Fernandez-Polo A, Gamez J, Garcia-Villoria J, Monteczuma EL, Leyes
P, Martín-Begué N, Oppenheimer F, et al: Cystinosis in adult and
adolescent patients: Recommendations for the comprehensive care of
cystinosis. Nefrologia. 35:304–321. 2015.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
16
|
Choudhary DS, Verma G, Kumar K, Choudhary
P, Kalal BS and Chaudhary A: Bowman's membrane lenticule tuck-in: A
new approach for the management of neurotrophic ulcers. Saudi J
Ophthalmol. 37:120–124. 2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bouazza N, Treluyer JM, Ottolenghi C,
Urien S, Deschenes G, Ricquier D, Niaudet P and Chadefaux-Vekemans
B: Population pharmacokinetics and pharmacodynamics of cysteamine
in nephropathic cystinosis patients. Orphanet J Rare Dis.
6(86)2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Iwata F, Kuehl EM, Reed GF, McCain LM,
Gahl WA and Kaiser-Kupfer MI: A randomized clinical trial of
topical cysteamine disulfide (cystamine) versus free thiol
(cysteamine) in the treatment of corneal cystine crystals in
cystinosis. Mol Genet Metab. 64:237–242. 1998.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ariceta G, Giordano V and Santos F:
Effects of long-term cysteamine treatment in patients with
cystinosis. Pediatr Nephrol. 34:571–578. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hohenfellner K, Bergmann C, Fleige T,
Janzen N, Burggraf S, Olgemoller B, Gahl WA, Czibere L, Froschauer
S, Röschinger W, et al: Molecular based newborn screening in
Germany: Follow-up for cystinosis. Mol Genet Metab Rep.
21(100514)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen TK, Knicely DH and Grams ME: Chronic
kidney disease diagnosis and management: A review. JAMA.
322:1294–1304. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hegde SK, Ranjit O, Bhat SS and Kalal BS:
Analysis of dental caries experience and parents perception on the
oral health status of children with autism spectrum disorders from
South India. Med J Bakirkoy. 20:189–195. 2024.
|
|
23
|
Elenberg E: Optimizing long-term outcomes
in cystinosis with comprehensive patient-centered Care. Kidney Int
Rep. 10:S775–S778. 2025.PubMed/NCBI View Article : Google Scholar
|
